Fundraising Fox

Regeneron NASDAQ: REGN www.regeneron.com

Tarrytown, US · 4 known investors

Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.

Investors · 4

Competitors · 2

by search overlap

Companies competing with Regeneron NASDAQ: REGN www.regeneron.com for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Regeneron NASDAQ: REGN www.regeneron.com do?
Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
Who are Regeneron NASDAQ: REGN www.regeneron.com's investors?
Regeneron NASDAQ: REGN www.regeneron.com's investors include Ridgeback Capital, Sanderling Ventures, venBio Partners, Wireframe Ventures.
Where is Regeneron NASDAQ: REGN www.regeneron.com headquartered?
Regeneron NASDAQ: REGN www.regeneron.com is headquartered in Tarrytown, US.